Eureka, City of Hope to Conduct Phase 1 Trial of Investigational CAR T-cell Therapy for Liver Cancer
Liver cancer, News
Eureka Therapeutics and City of Hope will jointly conduct a Phase 1 clinical trial of assessing Eureka’s investigational CAR T-cell therapy ET1402 for hepatocellular carcinoma (HCC), the most common type of liver cancer. “The clinical ... Read more